Name (Synonyms) | Correlation | |
---|---|---|
drug1129 | Folic Acid Wiki | 1.00 |
drug257 | Ascorbic Acid Wiki | 0.50 |
drug1301 | Hydroxychloroquine Sulfate Wiki | 0.28 |
drug313 | Azithromycin Wiki | 0.17 |
Name (Synonyms) | Correlation | |
---|---|---|
D055370 | Lung Injury NIH | 0.20 |
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.09 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.08 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This is a multicenter, single-treatment study. Subjects will consist of adults with COVID-19 associated acute lung injury who are being cared for in a critical care environment.
Description: The AUC for OI through 12 hours measured using the trapezoidal method, where OI is defined as mean airway pressure (Paw)×fraction of inspired oxygen (FiO2)×100/arterial pressure of oxygen (PaO2)
Measure: Oxygenation index (OI) area under the curve (AUC)0-12 Time: 12 hours post initiation of dosingDescription: FiO2 change from baseline
Measure: FiO2 Time: 24 hours post initiation of dosingDescription: PaO2 change from baseline
Measure: PaO2 Time: 24 hours post initiation of dosingDescription: SpO2 change from baseline
Measure: Oxygenation from pulse oximetry (SpO2) Time: 24 hours post initiation of dosingDescription: Change from baseline in P/F ratio, defined as PaO2/FiO2
Measure: P/F ratio Time: 24 hours post initiation of dosingDescription: Change from baseline in VI, defined as [respiration rate (RR)×(peak inspriatory pressure [PIP] − peak expiratory end pressure [PEEP])× arterial pressure of carbon dioxide (PaCO2)]/1000
Measure: Ventilation Index (VI) Time: 24 hours post initiation of dosingDescription: Change from baseline in lung compliance, as measured by the ventilator
Measure: Lung compliance Time: 24 hours post initiation of dosing